Previous close | 3.6500 |
Open | 3.6900 |
Bid | 3.8100 x 400 |
Ask | 3.8600 x 500 |
Day's range | 3.6450 - 3.9200 |
52-week range | 1.8100 - 11.3100 |
Volume | |
Avg. volume | 303,111 |
Market cap | 230.706M |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Q1 2024 Acumen Pharmaceuticals Inc Earnings Call
In this article, we will be taking a look at the 12 cheap foods with anti-aging properties that longevity scientists swear by. If you do not want to learn about the anti-aging trends, head straight to 5 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By. Anti-Aging Trends: Market Insights & Emerging Solutions Anti-aging […]